IOVANCE BIOTHERAPEUTICS, INC. (IOVA) /
The revenue of IOVANCE BIOTHERAPEUTICS, INC. over the past 10 years
Chart IOVANCE BIOTHERAPEUTICS, INC.: revenue, fiscal 2016–2025 Open the chart →IOVANCE BIOTHERAPEUTICS, INC. reported revenue of $263.5M in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $0. Year over year, revenue rose twice. The largest one-year move was in fiscal 2024: up 13699%, from $1.19M to $164.07M. No revenue figure is on file for fiscal 2019, 2020, 2021 and 2022.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $263.5M |
| 2024ended Dec 31, 2024 | $164.07M |
| 2023ended Dec 31, 2023 | $1.19M |
| 2022ended Dec 31, 2022 | — |
| 2021ended Dec 31, 2021 | — |
| 2020ended Dec 31, 2020 | — |
| 2019ended Dec 31, 2019 | — |
| 2018ended Dec 31, 2018 | $0 |
| 2017ended Dec 31, 2017 | $0 |
| 2016ended Dec 31, 2016 | $0 |
Fiscal years as IOVANCE BIOTHERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on IOVANCE BIOTHERAPEUTICS, INC.
- The profitability of IOVANCE BIOTHERAPEUTICS, INC.
- The cash flow of IOVANCE BIOTHERAPEUTICS, INC.
- The debt of IOVANCE BIOTHERAPEUTICS, INC.
- All of IOVANCE BIOTHERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- SMGScotts Miracle-Gro Co
- COCOThe Vita Coco Company, Inc.
- CNRCore Natural Resources, Inc.
- AZZAZZ Inc.
- KGSKodiak Gas Services, Inc.
Not investment advice. This page shows what IOVANCE BIOTHERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.